Paracrine regulation of matrix metalloproteinase expression in endometriosis

Annals of the New York Academy of Sciences

Volumn 955, Issue , 2002, Pages 147-156

  Sharpe Timms, Kathy L ^a   Cox, Kathryn E ^a  

^a University of Missouri   (United States)

Author keywords

Cytokines; Matrix metalloproteinases; MMP; Regulation; Steroids; TIMP; Tissue inhibitors of metalloproteinases

Indexed keywords

CYTOKINE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; STEROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; DEGRADATION; DISEASE COURSE; ENDOMETRIOSIS; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; IMMUNOCOMPETENT CELL; MENSTRUATION; NONHUMAN; PARACRINE SIGNALING; PERITONEAL FLUID; PERITONEUM CELL; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0036218057     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02775.x     Document Type: Conference Paper

References (75)

1. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity
2. The development of the implantation theory for the origin of peritoneal endometriosis
3. Status of current research on endometriosis
4. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis
5. Serial laparoscopies over 30 months show that endometriosis in captive baboons (Papio anubis, Papio cynocephalus) is a progressive disease
6. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
7. Matrix metalloproteinases in normal menstruation
8. Matrix metalloproteinases as mediators of reproductive function
9. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
10. Metalloproteinases and their inhibitors in matrix remodeling
11. Matrix metalloproteinases: A review
12. The matrix-degrading metalloproteinases
13. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions
14. Early endometriosis invades the extracellular matrix
15. Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol
16. Matrix metalloproteinases and their tissue inhibitors in antegradely shed menstruum and peritoneal fluid
17. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants
18. Differential regulation of matrix metalloproteinase-3 (MMP-3) gene expression in endometriotic lesions as compared to endometrium
19. Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveal homology with tissue inhibitor of metalloproteinases-1 (TIMP-1)
20. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy
21. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice
22. Basic research in endometriosis
23. Differential in vivo expression and localization of endometriosis protein-I (ENDO-I), a haptoglobin homologue, in endometrium and endometriotic lesions
24. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis
25. Progesterone receptor isoform A, but not B is expressed in endometriosis
26. Endometrial anomalies in women with endometriosis
27. Immunology and endometriosis: Fact, artifact, or epiphenomenon?
28. Novel implications in the development of endometriosis: Biphasic effect of macrophage activation on peritoneal tissue expression of tissue inhibitor of metalloproteinase-1
29. Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle
30. Phenotypic and functional studies of leukocytes in human endometrium and endometriosis
31. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B)
32. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors
33. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-β1
34. Identification of epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in surgically induced endometriosis in rats
35. Localization of transforming growth factor beta isoforms TGF-beta 1, TGF-beta 2, and TGF-beta 3 in surgically induced pelvic adhesions in the rat
36. Interleukin-1: A possible role in the infertility associated with endometriosis
37. Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis
38. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis
39. Regulation of matrix metalloproteinases during extracellular matrix turnover
40. Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts
41. Structure of the human type IV collagenase gene
42. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements: A mechanism regulating gene expression independent of that by inflammatory cytokines
43. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line
44. Regulation of proteolytic activity in tissues
45. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone
46. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region
47. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
48. Oncogenes control stromelysin and collagenase gene expression
49. The collagenase promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites
50. Transcriptional regulation of human stromelysin
51. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements
52. Regulation of matrix metalloproteinase gene expression
53. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1 binding site
54. Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have different effects on transcription and bind Jun D, c-Fos, and Fra-2
55. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via function interaction of AP-1 and Ets-1 transcription factors
56. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins
57. Oncogenic conversion alters the transcriptional properties of Ets
58. Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3)
59. Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA
60. TGF-β inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence
61. Differential regulation of collagenase gene expression by retinoic acid receptors-alpha, beta, and gamma
62. Nuclear receptor/AP-1 interaction
63. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity
64. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: Evidence for binding of RARs/RXRs to the -77 AP-1 site through interaction with c-Jun
65. Retinoic acid is a negative regulator of AP-1 responsive genes
66. Steroid hormone receptors: Interactions with deoxyribonucleic acid and transcription factors
67. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction
68. Urinary trypsin inhibitor suppresses the production of interstitial procollagenase/proMMP-1 and pro-stromelysin 1/proMMP-3 in human uterine cervical fibroblasts and chorionic cells
69. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1α in endometrial stromal cells
70. Interleukin-1α opposes progesterone-mediated suppression of MMP-7
71. Paracrine regulation of matrix metalloproteinase expression in the normal endometrium
72. Expression of the α2β1 and α3β1 integrins at the surface of mesothelial cells: A potential attachment site of endometrial cells
73. Whole explants of peritoneum and endometrium: A novel model of the early endometriosis lesion
74. Current concepts in the pathogenesis of endometriosis